Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-09-11
Pages: 173 Pages
Report ld: 5038815
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hemostats Market Size(US$)
CAGR 2025-2031
5.9%
Market Size,2031
USD 4,570
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 3,240 million
Market Forecast in 2031(Value)
US$ 4,570 million
CAGR
5.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Hemostats market is projected to grow from US$ 3076 million in 2024 to US$ 4570 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.
North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.
In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Hemostats market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Ethicon
- Pfizer
- Baxter International Inc.
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences Corporation
- B Braun Melsungen AG
- Gelita Medical GmbH
- Equimedical
- Vascular Solutions
- Marine Polymer Technologies
- Z-Medica, LLC
- CryoLife
- BioCer Entwicklungs-GmbH.
- Biom'Up SAS
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Thrombin-Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
- Combination Hemostats
- Gelatin Based Hemostats
- Collagen Based Hemostats
Segment by Application
- Prehospital Treatment
- Hospital Treatment
CHAPTER OUTLINE
Chapter 1: Defines the Hemostats study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Hemostats: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Hemostats Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Thrombin-Based Hemostats
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Combination Hemostats
1.2.5 Gelatin Based Hemostats
1.2.6 Collagen Based Hemostats
1.3 Market Segmentation by Application
1.3.1 Global Hemostats Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Prehospital Treatment
1.3.3 Hospital Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Hemostats Revenue Estimates and Forecasts 2020-2031
2.2 Global Hemostats Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Hemostats Sales Estimates and Forecasts 2020-2031
2.4 Global Hemostats Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Hemostats Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Hemostats Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Thrombin-Based Hemostats Market Size by Manufacturers
3.5.2 Oxidized Regenerated Cellulose Based Hemostats Market Size by Manufacturers
3.5.3 Combination Hemostats Market Size by Manufacturers
3.5.4 Gelatin Based Hemostats Market Size by Manufacturers
3.5.5 Collagen Based Hemostats Market Size by Manufacturers
3.6 Global Hemostats Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Hemostats Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Hemostats Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Hemostats Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Hemostats Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Hemostats Sales and Revenue by Type (2020-2031)
6.4 North America Hemostats Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Hemostats Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Hemostats Sales and Revenue by Type (2020-2031)
7.4 Europe Hemostats Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Hemostats Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Hemostats Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Hemostats Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Hemostats Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Hemostats Sales and Revenue by Type (2020-2031)
9.4 Central and South America Hemostats Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Hemostats Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Hemostats Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Hemostats Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Hemostats Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Ethicon
11.1.1 Ethicon Corporation Information
11.1.2 Ethicon Business Overview
11.1.3 Ethicon Hemostats Product Models, Descriptions and Specifications
11.1.4 Ethicon Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Ethicon Hemostats Sales by Product in 2024
11.1.6 Ethicon Hemostats Sales by Application in 2024
11.1.7 Ethicon Hemostats Sales by Geographic Area in 2024
11.1.8 Ethicon Hemostats SWOT Analysis
11.1.9 Ethicon Recent Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Hemostats Product Models, Descriptions and Specifications
11.2.4 Pfizer Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Pfizer Hemostats Sales by Product in 2024
11.2.6 Pfizer Hemostats Sales by Application in 2024
11.2.7 Pfizer Hemostats Sales by Geographic Area in 2024
11.2.8 Pfizer Hemostats SWOT Analysis
11.2.9 Pfizer Recent Developments
11.3 Baxter International Inc.
11.3.1 Baxter International Inc. Corporation Information
11.3.2 Baxter International Inc. Business Overview
11.3.3 Baxter International Inc. Hemostats Product Models, Descriptions and Specifications
11.3.4 Baxter International Inc. Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Baxter International Inc. Hemostats Sales by Product in 2024
11.3.6 Baxter International Inc. Hemostats Sales by Application in 2024
11.3.7 Baxter International Inc. Hemostats Sales by Geographic Area in 2024
11.3.8 Baxter International Inc. Hemostats SWOT Analysis
11.3.9 Baxter International Inc. Recent Developments
11.4 C. R. Bard
11.4.1 C. R. Bard Corporation Information
11.4.2 C. R. Bard Business Overview
11.4.3 C. R. Bard Hemostats Product Models, Descriptions and Specifications
11.4.4 C. R. Bard Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 C. R. Bard Hemostats Sales by Product in 2024
11.4.6 C. R. Bard Hemostats Sales by Application in 2024
11.4.7 C. R. Bard Hemostats Sales by Geographic Area in 2024
11.4.8 C. R. Bard Hemostats SWOT Analysis
11.4.9 C. R. Bard Recent Developments
11.5 The Medicines Company
11.5.1 The Medicines Company Corporation Information
11.5.2 The Medicines Company Business Overview
11.5.3 The Medicines Company Hemostats Product Models, Descriptions and Specifications
11.5.4 The Medicines Company Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 The Medicines Company Hemostats Sales by Product in 2024
11.5.6 The Medicines Company Hemostats Sales by Application in 2024
11.5.7 The Medicines Company Hemostats Sales by Geographic Area in 2024
11.5.8 The Medicines Company Hemostats SWOT Analysis
11.5.9 The Medicines Company Recent Developments
11.6 Anika Therapeutics
11.6.1 Anika Therapeutics Corporation Information
11.6.2 Anika Therapeutics Business Overview
11.6.3 Anika Therapeutics Hemostats Product Models, Descriptions and Specifications
11.6.4 Anika Therapeutics Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Anika Therapeutics Recent Developments
11.7 Advanced Medical Solutions
11.7.1 Advanced Medical Solutions Corporation Information
11.7.2 Advanced Medical Solutions Business Overview
11.7.3 Advanced Medical Solutions Hemostats Product Models, Descriptions and Specifications
11.7.4 Advanced Medical Solutions Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Advanced Medical Solutions Recent Developments
11.8 Integra LifeSciences Corporation
11.8.1 Integra LifeSciences Corporation Corporation Information
11.8.2 Integra LifeSciences Corporation Business Overview
11.8.3 Integra LifeSciences Corporation Hemostats Product Models, Descriptions and Specifications
11.8.4 Integra LifeSciences Corporation Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Integra LifeSciences Corporation Recent Developments
11.9 B Braun Melsungen AG
11.9.1 B Braun Melsungen AG Corporation Information
11.9.2 B Braun Melsungen AG Business Overview
11.9.3 B Braun Melsungen AG Hemostats Product Models, Descriptions and Specifications
11.9.4 B Braun Melsungen AG Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 B Braun Melsungen AG Recent Developments
11.10 Gelita Medical GmbH
11.10.1 Gelita Medical GmbH Corporation Information
11.10.2 Gelita Medical GmbH Business Overview
11.10.3 Gelita Medical GmbH Hemostats Product Models, Descriptions and Specifications
11.10.4 Gelita Medical GmbH Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Gelita Medical GmbH Recent Developments
11.11 Equimedical
11.11.1 Equimedical Corporation Information
11.11.2 Equimedical Business Overview
11.11.3 Equimedical Hemostats Product Models, Descriptions and Specifications
11.11.4 Equimedical Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Equimedical Recent Developments
11.12 Vascular Solutions
11.12.1 Vascular Solutions Corporation Information
11.12.2 Vascular Solutions Business Overview
11.12.3 Vascular Solutions Hemostats Product Models, Descriptions and Specifications
11.12.4 Vascular Solutions Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Vascular Solutions Recent Developments
11.13 Marine Polymer Technologies
11.13.1 Marine Polymer Technologies Corporation Information
11.13.2 Marine Polymer Technologies Business Overview
11.13.3 Marine Polymer Technologies Hemostats Product Models, Descriptions and Specifications
11.13.4 Marine Polymer Technologies Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.13.5 Marine Polymer Technologies Recent Developments
11.14 Z-Medica, LLC
11.14.1 Z-Medica, LLC Corporation Information
11.14.2 Z-Medica, LLC Business Overview
11.14.3 Z-Medica, LLC Hemostats Product Models, Descriptions and Specifications
11.14.4 Z-Medica, LLC Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.14.5 Z-Medica, LLC Recent Developments
11.15 CryoLife
11.15.1 CryoLife Corporation Information
11.15.2 CryoLife Business Overview
11.15.3 CryoLife Hemostats Product Models, Descriptions and Specifications
11.15.4 CryoLife Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.15.5 CryoLife Recent Developments
11.16 BioCer Entwicklungs-GmbH.
11.16.1 BioCer Entwicklungs-GmbH. Corporation Information
11.16.2 BioCer Entwicklungs-GmbH. Business Overview
11.16.3 BioCer Entwicklungs-GmbH. Hemostats Product Models, Descriptions and Specifications
11.16.4 BioCer Entwicklungs-GmbH. Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.16.5 BioCer Entwicklungs-GmbH. Recent Developments
11.17 Biom'Up SAS
11.17.1 Biom'Up SAS Corporation Information
11.17.2 Biom'Up SAS Business Overview
11.17.3 Biom'Up SAS Hemostats Product Models, Descriptions and Specifications
11.17.4 Biom'Up SAS Hemostats Sales, Price, Revenue and Gross Margin (2020-2025)
11.17.5 Biom'Up SAS Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Hemostats Industry Chain
12.2 Hemostats Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Hemostats Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Hemostats Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Hemostats Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Hemostats Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Hemostats Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Hemostats Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Hemostats Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Hemostats Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Hemostats Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Hemostats Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Pcs)
Table 7. Global Hemostats Sales by Region (2020-2025) & (K Pcs)
Table 8. Global Hemostats Sales by Region (2026-2031) & (K Pcs)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Hemostats Sales by Manufacturers (2020-2025) & (K Pcs)
Table 11. Global Hemostats Sales Share by Manufacturers (2020-2025)
Table 12. Global Hemostats Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global Hemostats Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global Hemostats by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemostats as of 2024)
Table 16. Global Hemostats Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global Hemostats Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/Pcs)
Table 18. Key Manufacturers Hemostats Manufacturing Base and Headquarters
Table 19. Global Hemostats Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global Hemostats Sales by Type (2020-2025) & (K Pcs)
Table 23. Global Hemostats Sales by Type (2026-2031) & (K Pcs)
Table 24. Global Hemostats Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global Hemostats Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global Hemostats ASP by Type (2020-2031) & (USD/Pcs)
Table 27. Technical Specifications by Key Product Type
Table 28. Global Hemostats Sales by Application (2020-2025) & (K Pcs)
Table 29. Global Hemostats Sales by Application (2026-2031) & (K Pcs)
Table 30. Hemostats High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global Hemostats Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global Hemostats Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global Hemostats ASP by Application (2020-2031) & (USD/Pcs)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America Hemostats Growth Accelerators and Market Barriers
Table 37. North America Hemostats Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America Hemostats Sales (K Pcs) by Country (2020 VS 2024 VS 2031)
Table 39. Europe Hemostats Growth Accelerators and Market Barriers
Table 40. Europe Hemostats Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe Hemostats Sales (K Pcs) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific Hemostats Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific Hemostats Sales (K Pcs) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific Hemostats Growth Accelerators and Market Barriers
Table 45. Southeast Asia Hemostats Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America Hemostats Investment Opportunities and Key Challenges
Table 47. Central and South America Hemostats Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa Hemostats Investment Opportunities and Key Challenges
Table 49. Middle East and Africa Hemostats Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Ethicon Corporation Information
Table 51. Ethicon Description and Major Businesses
Table 52. Ethicon Product Models, Descriptions and Specifications
Table 53. Ethicon Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 54. Ethicon Sales Value Proportion by Product in 2024
Table 55. Ethicon Sales Value Proportion by Application in 2024
Table 56. Ethicon Sales Value Proportion by Geographic Area in 2024
Table 57. Ethicon Hemostats SWOT Analysis
Table 58. Ethicon Recent Developments
Table 59. Pfizer Corporation Information
Table 60. Pfizer Description and Major Businesses
Table 61. Pfizer Product Models, Descriptions and Specifications
Table 62. Pfizer Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 63. Pfizer Sales Value Proportion by Product in 2024
Table 64. Pfizer Sales Value Proportion by Application in 2024
Table 65. Pfizer Sales Value Proportion by Geographic Area in 2024
Table 66. Pfizer Hemostats SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Baxter International Inc. Corporation Information
Table 69. Baxter International Inc. Description and Major Businesses
Table 70. Baxter International Inc. Product Models, Descriptions and Specifications
Table 71. Baxter International Inc. Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 72. Baxter International Inc. Sales Value Proportion by Product in 2024
Table 73. Baxter International Inc. Sales Value Proportion by Application in 2024
Table 74. Baxter International Inc. Sales Value Proportion by Geographic Area in 2024
Table 75. Baxter International Inc. Hemostats SWOT Analysis
Table 76. Baxter International Inc. Recent Developments
Table 77. C. R. Bard Corporation Information
Table 78. C. R. Bard Description and Major Businesses
Table 79. C. R. Bard Product Models, Descriptions and Specifications
Table 80. C. R. Bard Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 81. C. R. Bard Sales Value Proportion by Product in 2024
Table 82. C. R. Bard Sales Value Proportion by Application in 2024
Table 83. C. R. Bard Sales Value Proportion by Geographic Area in 2024
Table 84. C. R. Bard Hemostats SWOT Analysis
Table 85. C. R. Bard Recent Developments
Table 86. The Medicines Company Corporation Information
Table 87. The Medicines Company Description and Major Businesses
Table 88. The Medicines Company Product Models, Descriptions and Specifications
Table 89. The Medicines Company Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 90. The Medicines Company Sales Value Proportion by Product in 2024
Table 91. The Medicines Company Sales Value Proportion by Application in 2024
Table 92. The Medicines Company Sales Value Proportion by Geographic Area in 2024
Table 93. The Medicines Company Hemostats SWOT Analysis
Table 94. The Medicines Company Recent Developments
Table 95. Anika Therapeutics Corporation Information
Table 96. Anika Therapeutics Description and Major Businesses
Table 97. Anika Therapeutics Product Models, Descriptions and Specifications
Table 98. Anika Therapeutics Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 99. Anika Therapeutics Recent Developments
Table 100. Advanced Medical Solutions Corporation Information
Table 101. Advanced Medical Solutions Description and Major Businesses
Table 102. Advanced Medical Solutions Product Models, Descriptions and Specifications
Table 103. Advanced Medical Solutions Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 104. Advanced Medical Solutions Recent Developments
Table 105. Integra LifeSciences Corporation Corporation Information
Table 106. Integra LifeSciences Corporation Description and Major Businesses
Table 107. Integra LifeSciences Corporation Product Models, Descriptions and Specifications
Table 108. Integra LifeSciences Corporation Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 109. Integra LifeSciences Corporation Recent Developments
Table 110. B Braun Melsungen AG Corporation Information
Table 111. B Braun Melsungen AG Description and Major Businesses
Table 112. B Braun Melsungen AG Product Models, Descriptions and Specifications
Table 113. B Braun Melsungen AG Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 114. B Braun Melsungen AG Recent Developments
Table 115. Gelita Medical GmbH Corporation Information
Table 116. Gelita Medical GmbH Description and Major Businesses
Table 117. Gelita Medical GmbH Product Models, Descriptions and Specifications
Table 118. Gelita Medical GmbH Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 119. Gelita Medical GmbH Recent Developments
Table 120. Equimedical Corporation Information
Table 121. Equimedical Description and Major Businesses
Table 122. Equimedical Product Models, Descriptions and Specifications
Table 123. Equimedical Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 124. Equimedical Recent Developments
Table 125. Vascular Solutions Corporation Information
Table 126. Vascular Solutions Description and Major Businesses
Table 127. Vascular Solutions Product Models, Descriptions and Specifications
Table 128. Vascular Solutions Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 129. Vascular Solutions Recent Developments
Table 130. Marine Polymer Technologies Corporation Information
Table 131. Marine Polymer Technologies Description and Major Businesses
Table 132. Marine Polymer Technologies Product Models, Descriptions and Specifications
Table 133. Marine Polymer Technologies Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 134. Marine Polymer Technologies Recent Developments
Table 135. Z-Medica, LLC Corporation Information
Table 136. Z-Medica, LLC Description and Major Businesses
Table 137. Z-Medica, LLC Product Models, Descriptions and Specifications
Table 138. Z-Medica, LLC Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 139. Z-Medica, LLC Recent Developments
Table 140. CryoLife Corporation Information
Table 141. CryoLife Description and Major Businesses
Table 142. CryoLife Product Models, Descriptions and Specifications
Table 143. CryoLife Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 144. CryoLife Recent Developments
Table 145. BioCer Entwicklungs-GmbH. Corporation Information
Table 146. BioCer Entwicklungs-GmbH. Description and Major Businesses
Table 147. BioCer Entwicklungs-GmbH. Product Models, Descriptions and Specifications
Table 148. BioCer Entwicklungs-GmbH. Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 149. BioCer Entwicklungs-GmbH. Recent Developments
Table 150. Biom'Up SAS Corporation Information
Table 151. Biom'Up SAS Description and Major Businesses
Table 152. Biom'Up SAS Product Models, Descriptions and Specifications
Table 153. Biom'Up SAS Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 154. Biom'Up SAS Recent Developments
Table 155. Key Raw Materials Distribution
Table 156. Raw Materials Key Suppliers
Table 157. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 158. Milestones in Production Technology Evolution
Table 159. Distributors List
Table 160. Market Trends and Market Evolution
Table 161. Market Drivers and Opportunities
Table 162. Market Challenges, Risks, and Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemostats Product Picture
Figure 2. Global Hemostats Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Thrombin-Based Hemostats Product Picture
Figure 4. Oxidized Regenerated Cellulose Based Hemostats Product Picture
Figure 5. Combination Hemostats Product Picture
Figure 6. Gelatin Based Hemostats Product Picture
Figure 7. Collagen Based Hemostats Product Picture
Figure 8. Global Hemostats Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 9. Prehospital Treatment
Figure 10. Hospital Treatment
Figure 11. Hemostats Report Years Considered
Figure 12. Global Hemostats Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Hemostats Revenue (2020-2031) & (US$ Million)
Figure 14. Global Hemostats Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 15. Global Hemostats Revenue Market Share by Region (2020-2031)
Figure 16. Global Hemostats Sales (2020-2031) & (K Pcs)
Figure 17. Global Hemostats Sales (CAGR) by Region (2020-2031) (K Pcs)
Figure 18. Global Hemostats Sales Market Share by Region (2020-2031)
Figure 19. Top 5 and Top 10 Manufacturers Hemostats Sales Volume Market Share in 2024
Figure 20. Global Hemostats Revenue Market Share Ranking (2024)
Figure 21. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 22. Thrombin-Based Hemostats Revenue Market Share by Manufacturer in 2024
Figure 23. Oxidized Regenerated Cellulose Based Hemostats Revenue Market Share by Manufacturer in 2024
Figure 24. Combination Hemostats Revenue Market Share by Manufacturer in 2024
Figure 25. Gelatin Based Hemostats Revenue Market Share by Manufacturer in 2024
Figure 26. Collagen Based Hemostats Revenue Market Share by Manufacturer in 2024
Figure 27. Global Hemostats Sales Market Share by Type (2020-2031)
Figure 28. Global Hemostats Revenue Market Share by Type (2020-2031)
Figure 29. Global Hemostats Sales Market Share by Application (2020-2031)
Figure 30. Global Hemostats Revenue Market Share by Application (2020-2031)
Figure 31. North America Hemostats Sales YoY (2020-2031) & (K Pcs)
Figure 32. North America Hemostats Revenue YoY (2020-2031) & (US$ Million)
Figure 33. North America Top 5 Manufacturers Hemostats Sales Revenue (US$ Million) in 2024
Figure 34. North America Hemostats Sales Volume (K Pcs) by Type (2020- 2031)
Figure 35. North America Hemostats Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 36. North America Hemostats Sales Volume (K Pcs) by Application (2020-2031)
Figure 37. North America Hemostats Sales Revenue (US$ Million) by Application (2020-2031)
Figure 38. US Hemostats Revenue (2020-2031) & (US$ Million)
Figure 39. Canada Hemostats Revenue (2020-2031) & (US$ Million)
Figure 40. Mexico Hemostats Revenue (2020-2031) & (US$ Million)
Figure 41. Europe Hemostats Sales YoY (2020-2031) & (K Pcs)
Figure 42. Europe Hemostats Revenue YoY (2020-2031) & (US$ Million)
Figure 43. Europe Top 5 Manufacturers Hemostats Sales Revenue (US$ Million) in 2024
Figure 44. Europe Hemostats Sales Volume (K Pcs) by Type (2020-2031)
Figure 45. Europe Hemostats Sales Revenue (US$ Million) by Type (2020-2031)
Figure 46. Europe Hemostats Sales Volume (K Pcs) by Application (2020-2031)
Figure 47. Europe Hemostats Sales Revenue (US$ Million) by Application (2020-2031)
Figure 48. Germany Hemostats Revenue (2020-2031) & (US$ Million)
Figure 49. France Hemostats Revenue (2020-2031) & (US$ Million)
Figure 50. U.K. Hemostats Revenue (2020-2031) & (US$ Million)
Figure 51. Italy Hemostats Revenue (2020-2031) & (US$ Million)
Figure 52. Russia Hemostats Revenue (2020-2031) & (US$ Million)
Figure 53. Asia-Pacific Hemostats Sales YoY (2020-2031) & (K Pcs)
Figure 54. Asia-Pacific Hemostats Revenue YoY (2020-2031) & (US$ Million)
Figure 55. Asia-Pacific Top 8 Manufacturers Hemostats Sales Revenue (US$ Million) in 2024
Figure 56. Asia-Pacific Hemostats Sales Volume (K Pcs) by Type (2020- 2031)
Figure 57. Asia-Pacific Hemostats Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 58. Asia-Pacific Hemostats Sales Volume (K Pcs) by Application (2020-2031)
Figure 59. Asia-Pacific Hemostats Sales Revenue (US$ Million) by Application (2020-2031)
Figure 60. Indonesia Hemostats Revenue (2020-2031) & (US$ Million)
Figure 61. Japan Hemostats Revenue (2020-2031) & (US$ Million)
Figure 62. South Korea Hemostats Revenue (2020-2031) & (US$ Million)
Figure 63. China Taiwan Hemostats Revenue (2020-2031) & (US$ Million)
Figure 64. India Hemostats Revenue (2020-2031) & (US$ Million)
Figure 65. Central and South America Hemostats Sales YoY (2020-2031) & (K Pcs)
Figure 66. Central and South America Hemostats Revenue YoY (2020-2031) & (US$ Million)
Figure 67. Central and South America Top 5 Manufacturers Hemostats Sales Revenue (US$ Million) in 2024
Figure 68. Central and South America Hemostats Sales Volume (K Pcs) by Type (2021-2031)
Figure 69. Central and South America Hemostats Sales Revenue (US$ Million) by Type (2020-2031)
Figure 70. Central and South America Hemostats Sales Volume (K Pcs) by Application (2020-2031)
Figure 71. Central and South America Hemostats Sales Revenue (US$ Million) by Application (2020-2031)
Figure 72. Brazil Hemostats Revenue (2020-2025) & (US$ Million)
Figure 73. Argentina Hemostats Revenue (2020-2025) & (US$ Million)
Figure 74. Middle East, and Africa Hemostats Sales YoY (2020-2031) & (K Pcs)
Figure 75. Middle East and Africa Hemostats Revenue YoY (2020-2031) & (US$ Million)
Figure 76. Middle East and Africa Top 5 Manufacturers Hemostats Sales Revenue (US$ Million) in 2024
Figure 77. Middle East and Africa Hemostats Sales Volume (K Pcs) by Type (2021-2031)
Figure 78. South America Hemostats Sales Revenue (US$ Million) by Type (2020-2031)
Figure 79. Middle East and Africa Hemostats Sales Volume (K Pcs) by Application (2020-2031)
Figure 80. Middle East and Africa Hemostats Sales Revenue (US$ Million) by Application (2020-2031)
Figure 81. GCC Countries Hemostats Revenue (2020-2025) & (US$ Million)
Figure 82. Turkey Hemostats Revenue (2020-2025) & (US$ Million)
Figure 83. Egypt Hemostats Revenue (2020-2025) & (US$ Million)
Figure 84. South Africa Hemostats Revenue (2020-2025) & (US$ Million)
Figure 85. Hemostats Industry Chain Mapping
Figure 86. Regional Hemostats Manufacturing Base Distribution (%)
Figure 87. Global Hemostats Production Market Share by Region (2020-2031)
Figure 88. Hemostats Production Process
Figure 89. Regional Hemostats Production Cost Structure
Figure 90. Channels of Distribution (Direct Vs Distribution)
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 5.9% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What was the global market size of Hemostats in 2025?
Which companies rank high in the global Hemostats market?
What is the annual compound growth rate of the global Hemostats market size from 2025 to 2031?
What was the global market size of Hemostats in 2031?
Related Reports
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hemostats market is projected to grow from US$ 2239 million in 2025 to US$ 3316 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-08
Pages: 175
USD 4900.00
(Single User License)
Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostats market size was US$ 2239 million in 2025 and is forecast to reach a readjusted size of US$ 3316 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-03-08
Pages: 104
USD 4250.00
(Single User License)
Global Hemostats Market Research Report 2026
The global Hemostats market was valued at US$ 2239 million in 2025 and is anticipated to reach US$ 3316 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 134
USD 2900.00
(Single User License)
Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostats was estimated to be worth US$ 2239 million in 2025 and is projected to reach US$ 3316 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 143
USD 3950.00
(Single User License)
Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostats was estimated to be worth US$ 3076 million and is forecast to reach approximately US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 162
USD 5900.00
(Single User License)
Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostats market size was US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 106
USD 4250.00
(Single User License)
Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostats was estimated to be worth US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 150
USD 3950.00
(Single User License)
Global Hemostats Market Research Report 2025
The global market for Hemostats was valued at US$ 3076 million in the year 2024 and is projected to reach a revised size of US$ 4570 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-01-16
Pages: 106
USD 2900.00
(Single User License)
Global Hemostats Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published Date: 2024-04-17
Pages: 182
USD 5600.00
(Single User License)
Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published Date: 2024-04-16
Pages: 160
USD 5900.00
(Single User License)
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hemostats market is projected to grow from US$ 2239 million in 2025 to US$ 3316 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-08
Pages: 175
USD 4900.00 (Single User License)Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostats market size was US$ 2239 million in 2025 and is forecast to reach a readjusted size of US$ 3316 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-03-08
Pages: 104
USD 4250.00 (Single User License)Global Hemostats Market Research Report 2026
The global Hemostats market was valued at US$ 2239 million in 2025 and is anticipated to reach US$ 3316 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-08
Pages: 134
USD 2900.00 (Single User License)Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostats was estimated to be worth US$ 2239 million in 2025 and is projected to reach US$ 3316 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-08
Pages: 143
USD 3950.00 (Single User License)Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostats was estimated to be worth US$ 3076 million and is forecast to reach approximately US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 162
USD 5900.00 (Single User License)Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostats market size was US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 106
USD 4250.00 (Single User License)Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostats was estimated to be worth US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 150
USD 3950.00 (Single User License)Global Hemostats Market Research Report 2025
The global market for Hemostats was valued at US$ 3076 million in the year 2024 and is projected to reach a revised size of US$ 4570 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-01-16
Pages: 106
USD 2900.00 (Single User License)Global Hemostats Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published: 2024-04-17
Pages: 182
USD 5600.00 (Single User License)Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published: 2024-04-16
Pages: 160
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now